NIOSOMES VERSUS PRONIOSOMES AS PROMISING DRUG DELIVERY SYSTEMS IN TREATMENT OF DIABETES MELLITUS
Keywords:Diabetes Mellitus (DM), Niosomes, Proniosomes
Diabetes Mellitus (DM) has emerged as an epidemic that has affected millions of people globally in the last few decades. Conventional antidiabetic dosage forms have a lot of problems that necessitate searching for novel drug delivery systems to overcome these drawbacks. Niosomes and proniosomes have been used to carry a wide variety of antidiabetic drugs achieving controlled and sustained release which improves patient compliance. This review article describes the fundamental aspects of niosomes and proniosomes including their structural components, methods of preparation, advantages and drawbacks, characterization, factors affecting niosomes formation along with their application in treatment of diabetes. It also highlights the participation of other drug delivery systems in treatment of diabetes done mainly in the last decade.
Artasensi A, Pedretti A, Vistoli G, Fumagalli L. Type 2 diabetes mellitus: A review of multi-target drugs. Molecules. 2020;25(8):1–20.
Matzinger M, Fischhuber K, Heiss EH. Activation of Nrf2 signaling by natural products-can it alleviate diabetes? Biotechnol Adv [Internet]. 2018;36(6):1738–67. Available from: http://dx.doi.org/10.1016/j.biotechadv.2017.12.015
Khursheed R, Singh SK, Wadhwa S, Kapoor B, Gulati M, Kumar R, et al. Treatment strategies against diabetes: Success so far and challenges ahead. Eur J Pharmacol [Internet]. 2019;862(August):172625. Available from: https://doi.org/10.1016/j.ejphar.2019.172625
Ensign LM, Cone R, Hanes J. Oral drug delivery with polymeric nanoparticles: The gastrointestinal mucus barriers. Adv Drug Deliv Rev [Internet]. 2012;64(6):557–70. Available from: http://dx.doi.org/10.1016/j.addr.2011.12.009
Rai VK, Mishra N, Agrawal AK, Jain S, Yadav NP. Novel drug delivery system: an immense hope for diabetics. Drug Deliv [Internet]. 2016;23(7):2371–90. Available from: http://dx.doi.org/10.3109/10717544.2014.991001
Mir M, Ishtiaq S, Rabia S, Khatoon M, Zeb A, Khan GM, et al. Nanotechnology: from In Vivo Imaging System to Controlled Drug Delivery. Nanoscale Res Lett. 2017;12.
Bochot A, Fattal E. Liposomes for intravitreal drug delivery: A state of the art. J Control Release [Internet]. 2012;161(2):628–34. Available from: http://dx.doi.org/10.1016/j.jconrel.2012.01.019
Ahmad M, Akhter S, Mohsin N, Abdel-Wahab B, Ahmad J, Warsi M, et al. Transformation of Curcumin from Food Additive to Multifunctional Medicine: Nanotechnology Bridging the Gap. Curr Drug Discov Technol. 2014;11(3):197–213.
Kamel R, Basha M, Abd El-Alim SH. Development of a novel vesicular system using a binary mixture of sorbitan monostearate and polyethylene glycol fatty acid esters for rectal delivery of rutin. J Liposome Res. 2013;23(1):28–36.
Khatoon M, Shah KU, Din FU, Shah SU, Rehman AU, Dilawar N, et al. Proniosomes derived niosomes: recent advancements in drug delivery and targeting. Drug Deliv [Internet]. 2017;24(2):56–69. Available from: https://doi.org/10.1080/10717544.2017.1384520
Care D, Suppl SS. Classification and diagnosis of diabetes: Standards of medical care in Diabetesd2018. Diabetes Care. 2018;41(January):S13–27.
Zaric BL, Obradovic M, Sudar-Milovanovic E, Nedeljkovic J, Lazic V, Isenovic ER. Drug Delivery Systems for Diabetes Treatment. Curr Pharm Des. 2019;25(2):166–73.
Chaudhury A, Duvoor C, Reddy Dendi VS, Kraleti S, Chada A, Ravilla R, et al. Clinical Review of Antidiabetic Drugs: Implications for Type 2 Diabetes Mellitus Management. Front Endocrinol (Lausanne). 2017;8(January).
Sola D, Rossi L, Schianca GPC, Maffioli P, Bigliocca M, Mella R, et al. Sulfonylureas and their use in clinical practice. Arch Med Sci. 2015;11(4):840–8.
Davidson MA, Mattison DR, Azoulay L, Krewski D. Thiazolidinedione drugs in the treatment of type 2 diabetes mellitus: past, present and future. Crit Rev Toxicol [Internet]. 2018;48(1):52–108. Available from: https://doi.org/10.1080/10408444.2017.135142016. Abdelkader H, Alani AWG, Alany RG. Recent advances in non-ionic surfactant vesicles (niosomes): Self-assembly, fabrication, characterization, drug delivery applications and limitations. Drug Deliv. 2014;21(2):87–100.
Ammar HO, Haider M, Ibrahim M, El Hoffy NM. In vitro and in vivo investigation for optimization of niosomal ability for sustainment and bioavailability enhancement of diltiazem after nasal administration. Drug Deliv. 2017;24(1):414–21.
Arafa MG, Ghalwash D, El-kersh DM, Elmazar MM. Propolis-based niosomes as oromuco-adhesive films : A randomized clinical trial of a therapeutic drug delivery platform for the treatment of oral recurrent aphthous ulcers. Sci Rep [Internet]. 2018;(November):1–14. Available from: http://dx.doi.org/10.1038/s41598-018-37157-7
Salem HF, Kharshoum RM, Abou-Taleb HA, Farouk HO, Zaki RM. Fabrication and appraisal of simvastatin via tailored niosomal nanovesicles for transdermal delivery enhancement: In vitro and in vivo assessment. Pharmaceutics. 2021;13(2):1–25.
Auda SH, Fathalla D, Fetih G, El-Badry M, Shakeel F. Niosomes as transdermal drug delivery system for celecoxib: in vitro and in vivo studies. Polym Bull. 2016;73(5):1229–45.
Fathalla D, Fouad EA, Soliman GM. Latanoprost niosomes as a sustained release ocular delivery system for the management of glaucoma. Drug Dev Ind Pharm [Internet]. 2020;46(5):806–13. Available from: http://dx.doi.org/10.1080/03639045.2020.1755305
Abdelbary GA, Amin MM, Zakaria MY. Ocular ketoconazole-loaded proniosomal gels: Formulation, ex vivo corneal permeation and in vivo studies. Drug Deliv. 2017;24(1):309–19.
Emad Eldeeb A, Salah S, Ghorab M. Proniosomal gel-derived niosomes: an approach to sustain and improve the ocular delivery of brimonidine tartrate; formulation, in-vitro characterization, and in-vivo pharmacodynamic study. Drug Deliv [Internet]. 2019;26(1):509–21. Available from: https://doi.org/10.1080/10717544.2019.1609622
Seleci DA, Seleci M, Walter J, Stahl F, Scheper T. Niosomes as Nanoparticular Drug Carriers : Fundamentals and Recent Applications. 2016;2016(Figure 1).
Aher P, Dandgavhal K, Bhandari D, Saindane H, Deore N, Amrutkar S. Niosomes as a Potential Drug Delivery System. Int J Pharm Sci Rev Res. 2021;68(1):21–7.
Azeem A, Anwer MK, Talegaonkar S. Niosomes in sustained and targeted drug delivery: Some recent advances. J Drug Target. 2009;17(9):671–89.
Bhardwaj P, Tripathi P, Gupta R, Pandey S. Niosomes: A review on niosomal research in the last decade. J Drug Deliv Sci Technol [Internet]. 2020;56(January):101581. Available from: https://doi.org/10.1016/j.jddst.2020.101581
Zhou X, Hao Y, Yuan L, Pradhan S, Shrestha K, Pradhan O, et al. Nano-formulations for transdermal drug delivery: A review. Chinese Chem Lett. 2018;29(12):1713–24.
Yeo PL, Lim CL, Chye SM, Ling APK, Koh RY. Niosomes: A review of their structure, properties, methods of preparation, and medical applications. Asian Biomed. 2017;11(4):301–13.
Moghassemi S, Hadjizadeh A. Nano-niosomes as nanoscale drug delivery systems: An illustrated review. J Control Release [Internet]. 2014;185(1):22–36. Available from: http://dx.doi.org/10.1016/j.jconrel.2014.04.015
Khoee S, Yaghoobian M. Niosomes: a novel approach in modern drug delivery systems [Internet]. Nanostructures for Drug Delivery. Elsevier Inc.; 2017. 207–237 p. Available from: http://dx.doi.org/10.1016/B978-0-323-46143-6/00006-3
Waddad AY, Abbad S, Yu F, Munyendo WLL, Wang J, Lv H, et al. Formulation, characterization and pharmacokinetics of Morin hydrate niosomes prepared from various non-ionic surfactants. Int J Pharm [Internet]. 2013;456(2):446–58. Available from: http://dx.doi.org/10.1016/j.ijpharm.2013.08.040
Nasr M, Mansour S, Mortada ND, Elshamy AA. Vesicular aceclofenac systems: A comparative study between liposomes and niosomes. J Microencapsul. 2008;25(7):499–512.
Master AM, Rodriguez ME, Kenney ME, Oleinick NL, Sen Gupta A. Delivery of the photosensitizer Pc 4 in PEG–PCL micelles for in vitro PDT studies. J Pharm Sci [Internet]. 2010;99(5):2386–2398. Available from: http://onlinelibrary.wiley.com/doi/10.1002/jps.22007/full%5Cnhttp://www.ncbi.nlm.nih.gov/pubmed/19967780
Saraswathi TS, Mothilal M, Jaganathan MK. Niosomes as an emerging formulation tool for drug delivery-a review. Int J Appl Pharm. 2019;11(2):7–15.
Uchegbu IF, Vyas SP. Non-ionic surfactant based vesicles (niosomes) in drug delivery. Int J Pharm. 1998;172(1–2):33–70.
Ammar HO, Ghorab M, El-Nahhas SA, Higazy IM. Proniosomes as a carrier system for transdermal delivery of tenoxicam. Int J Pharm [Internet]. 2011;405(1–2):142–52. Available from: http://dx.doi.org/10.1016/j.ijpharm.2010.11.003
Masjedi M, Montahaei T. An illustrated review on nonionic surfactant vesicles (niosomes) as an approach in modern drug delivery: Fabrication, characterization, pharmaceutical, and cosmetic applications. Vol. 61, Journal of Drug Delivery Science and Technology. Editions de Sante; 2021.
Gharbavi M, Amani J, Kheiri-Manjili H, Danafar H, Sharafi A. Niosome: A Promising Nanocarrier for Natural Drug Delivery through Blood-Brain Barrier. Adv Pharmacol Sci. 2018;2018.
Amoabediny G, Haghiralsadat F, Naderinezhad S, Helder MN, Akhoundi Kharanaghi E, Mohammadnejad Arough J, et al. Overview of preparation methods of polymeric and lipid-based (niosome, solid lipid, liposome) nanoparticles: A comprehensive review. Int J Polym Mater Polym Biomater. 2018;67(6):383–400.
Marianecci C, Di Marzio L, Rinaldi F, Celia C, Paolino D, Alhaique F, et al. Niosomes from 80s to present: The state of the art. Adv Colloid Interface Sci [Internet]. 2014;205:187–206. Available from: http://dx.doi.org/10.1016/j.cis.2013.11.018
Manconi M, Sinico C, Valenti D, Loy G, Fadda AM. Niosomes as carriers for tretinoin . I . Preparation and properties. 2002;234:237–48.
Uchegbu IF, Duncan R. Niosomes containing N-(2-hydroxypropyl)methacrylamide copolymer-doxorubicin (PK1): Effect of method of preparation and choice of surfactant on niosome characteristics and a preliminary study of body distribution. Int J Pharm. 1997;155(1):7–17.
Thabet Y, Elsabahy M, Eissa NG. Methods for preparation of niosomes : A focus on thin-film hydration method. Methods [Internet]. 2021;(April):1–7. Available from: https://doi.org/10.1016/j.ymeth.2021.05.004
Yaghoobian M, Haeri A, Bolourchian N, Shahhosseni S, Dadashzadeh S. The impact of surfactant composition and surface charge of niosomes on the oral absorption of repaglinide as a BCS II model drug. Int J Nanomedicine. 2020;15:8767–81.
Mohsen AM, AbouSamra MM, ElShebiney SA. Enhanced oral bioavailability and sustained delivery of glimepiride via niosomal encapsulation: in-vitro characterization and in-vivo evaluation. Drug Dev Ind Pharm [Internet]. 2017;43(8):1254–64. Available from: http://dx.doi.org/10.1080/03639045.2017.1310224
Chen S, Hanning S, Falconer J, Locke M, Wen J. Recent advances in non-ionic surfactant vesicles (niosomes): Fabrication, characterization, pharmaceutical and cosmetic applications. Eur J Pharm Biopharm [Internet]. 2019;144(August):18–39. Available from: https://doi.org/10.1016/j.ejpb.2019.08.015
Patel P, Barot T, Kulkarni P. Formulation, Characterization and In-vitro and In-vivo Evaluation of Capecitabine Loaded Niosomes. Curr Drug Deliv. 2020;17(3):257–68.
A RZM, B KD, C RBB. NIOSOMAL DRUG DELIVERY SYSTEM – A REVIEW A c a d e m i c S c i e n c e s. 2014;(January 2011).
Bendas ER, Abdullah H, El-Komy MHM, Kassem MAA. Hydroxychloroquine niosomes: A new trend in topical management of oral lichen planus. Int J Pharm [Internet]. 2013;458(2):287–95. Available from: http://dx.doi.org/10.1016/j.ijpharm.2013.10.042
Kusuma Priya MD, Kumar V, Damini VK, Eswar K, Reddy KR, Brito Raj S, et al. Somes: A review on composition, formulation methods and evaluations of different types of “somes” drug delivery system. Int J Appl Pharm. 2020;12(6):7–18.
Bhattacharya S, Kumar N, Singhai M, Setia A, Chaudhary A, Sagar S, et al. Preparation and Evaluation of Diclofenac Sodium Niosomes Using Round Bottom Flask Method. Asian J Pharm [Internet]. 2020;14(2):188–94. Available from: https://www.asiapharmaceutics.info/index.php/ajp/article/view/3613
Talsma H, Van Steenbergen MJ, Borchert JCH, Crommelin DJA. A novel technique for the one‐step preparation of liposomes and nonionic surfactant vesicles without the use of organic solvents. Liposome formation in a continuous gas stream: The ‘Bubble’ method. J Pharm Sci. 1994;83(3):276–80.
More V V, Gilhotra RM, Nitalikar MM, Khule PK. Niosomal drug delivery - A comprehensive review. Asian J Pharm. 2018 Oct 1;12:S1159–64.
Sankar V, Ruckmani K, Durga S, Jailani S. Proniosomes as drug carriers. Pak J Pharm Sci. 2010;23(1):103–7.
Mozafari MR. A new technique for the preparation of non-toxic liposomes and nanoliposomes: the heating method. Nanoliposomes From Fundam to Recent Dev. 2005;(December):91–8.
Mozafari MR, Reed CJ, Rostron C. Cytotoxicity evaluation of anionic nanoliposomes and nanolipoplexes prepared by the heating method without employing volatile solvents and detergents. Pharmazie. 2007;62(3):205–9.
Mozafari MR, Reed CJ, Rostron C, Kocum C, Piskin E. Construction of stable anionic liposome-plasmid particles using the heating method: A preliminary investigation. Cell Mol Biol Lett. 2002;7(3):923–7.
Rajera R, Nagpal K, Singh SK, Mishra DN. Niosomes: A controlled and novel drug delivery system. Biol Pharm Bull. 2011;34(7):945–53.
Paecharoenchai O, Teng L, Yung BC, Teng L, Opanasopit P, Lee RJ. Nonionic surfactant vesicles for delivery of RNAi therapeutics. Nanomedicine. 2013;8(11):1865–73.
El-Laithy HM, Shoukry O, Mahran LG. Novel sugar esters proniosomes for transdermal delivery of vinpocetine: Preclinical and clinical studies. Eur J Pharm Biopharm [Internet]. 2011;77(1):43–55. Available from: http://dx.doi.org/10.1016/j.ejpb.2010.10.011
El Maghraby GM, Ahmed AA, Osman MA. Penetration enhancers in proniosomes as a new strategy for enhanced transdermal drug delivery. Saudi Pharm J [Internet]. 2015;23(1):67–74. Available from: http://dx.doi.org/10.1016/j.jsps.2014.05.001
Madan JR, Ghuge NP, Dua K. Formulation and evaluation of proniosomes containing lornoxicam. Drug Deliv Transl Res [Internet]. 2016;6(5):511–8. Available from: http://dx.doi.org/10.1007/s13346-016-0296-9
SHAKER DS. Bioavailability and hypocholesterolemic effect of proniosomal simvastatin for transdermal delivery. Int J Pharm Pharm Sci. 2013;5(4):344–51.
Rahman SA, Abdelmalak NS, Badawi A, Elbayoumy T, Sabry N, Ramly A El. Formulation of tretinoin-loaded topical proniosomes for treatment of acne: In-vitro characterization, skin irritation test and comparative clinical study. Drug Deliv. 2015;22(6):731–9.
Ge X, Wei M, He S, Yuan WE. Advances of non-ionic surfactant vesicles (niosomes) and their application in drug delivery. Pharmaceutics. 2019;11(2).
Yasam VR, Jakki SL, Natarajan J, Kuppusamy G. A review on novel vesicular drug delivery: Proniosomes. Drug Deliv. 2014;21(4):243–9.
Vora B, Khopade AJ, Jain NK. Proniosome based transdermal delivery of levonorgestrel for effective contraception. J Control Release. 1998;54(2):149–65.
Ahmad MZ, Mohammed AA, Mokhtar Ibrahim M. Technology overview and drug delivery application of proniosome. Pharm Dev Technol. 2017;22(3):302–11.
Asthana GS, Sharma PK, Asthana A. In Vitro and in Vivo Evaluation of Niosomal Formulation for Controlled Delivery of Clarithromycin. Scientifica (Cairo). 2016;2016.
G DB, P VL. Recent advances of non-ionic surfactant-based nano-vesicles (niosomes and proniosomes): a brief review of these in enhancing transdermal delivery of drug. Futur J Pharm Sci. 2020;6(1).
Kumar GP, Rajeshwarrao P. Nonionic surfactant vesicular systems for effective drug delivery—an overview. Acta Pharm Sin B [Internet]. 2011;1(4):208–19. Available from: http://dx.doi.org/10.1016/j.apsb.2011.09.002
A RZM, B RBB. Niosomes - challenge in preparation for pharmaceutical scientist A c a d e m i c S c i e n c e s. 2014;(January 2011).
Iii III. Current techniques series. 1984;258–60.
Peltonen L, Koistinen P, Karjalainen M, Häkkinen A, Hirvonen J. The effect of cosolvents on the formulation of nanoparticles from low-molecular-weight poly(l)lactide. AAPS PharmSciTech. 2002;3(4):1–7.
Manosroi A, Khanrin P, Lohcharoenkal W, Werner RG, Götz F, Manosroi W, et al. Transdermal absorption enhancement through rat skin of gallidermin loaded in niosomes. Int J Pharm [Internet]. 2010;392(1–2):304–10. Available from: http://dx.doi.org/10.1016/j.ijpharm.2010.03.064
Mahale NB, Thakkar PD, Mali RG, Walunj DR, Chaudhari SR. Niosomes: Novel sustained release nonionic stable vesicular systems - An overview. Adv Colloid Interface Sci [Internet]. 2012;183–184:46–54. Available from: http://dx.doi.org/10.1016/j.cis.2012.08.002
Ruckmani K, Sankar V. Formulation and optimization of zidovudine niosomes. AAPS PharmSciTech. 2010;11(3):1119–27.
Nasseri B. Effect of cholesterol and temperature on the elastic properties of niosomal membranes. Int J Pharm. 2005;300(1–2):95–101.
Yeo LK, Chaw CS, Elkordy AA. The effects of hydration parameters and co-surfactants on methylene blue-loaded niosomes prepared by the thin film hydration method. Pharmaceuticals. 2019;12(2).
Ramkanth S, Chetty CM, Sudhakar Y, Thiruvengadarajan VS, Anitha P, Gopinath C. Development, characterization & invivo evaluation of proniosomal based transdermal delivery system of Atenolol. Futur J Pharm Sci [Internet]. 2018;4(1):80–7. Available from: https://doi.org/10.1016/j.fjps.2017.10.003
Nasr A, Qushawy M, Swidan S. Spray dried lactose based proniosomes as stable provesicular drug delivery carriers: Screening, formulation, and physicochemical characterization. Int J Appl Pharm. 2018;10(5):125–37.
KAOUD RM, HEIKAL EJ, HAMMADY TM. Diacerein-Loaded Niosomes (Dc-Ns): a New Technique To Sustain the Release of Drug Action. Int J Appl Pharm. 2022;14(1):156–63.
Jadhav A, Cheriyan BV. Formulation and optimization of nifedipine loaded nanocarriers. Int J Appl Pharm. 2021;13(5):311–7.
Manconi M, Valenti D, Sinico C, Lai F, Loy G, Fadda AM. Niosomes as carriers for tretinoin: II. Influence of vesicular incorporation on tretinoin photostability. Int J Pharm. 2003;260(2):261–72.
Sultan AA, El-Gizawy SA, Osman MA, El Maghraby GM. Niosomes for oral delivery of nateglinide: in situ–in vivo correlation. Vol. 28, Journal of Liposome Research. Taylor & Francis; 2018. 209–217 p.
Abdallah MH, Sabry SA, Hasan AA. Enhancing transdermal delivery of glimepiride via entrapment in proniosomal gel. J Young Pharm. 2016;8(4):335–40.
Haider MF, Kanoujia J, Tripathi CB, Arya M, Kaithwas G, Saraf SA. Pioglitazone Loaded Vesicular Carriers for Anti-Diabetic Activity: Development and Optimization as Per Central Composite Design. J Pharm Sci Pharmacol [Internet]. 2015 Mar 1 [cited 2021 Jan 26];2(1):11–20. Available from: http://openurl.ingenta.com/content/xref?genre=article&issn=2333-3715&volume=2&issue=1&spage=11
Namdev S, Gujar K, Mandlik S, Jamkar P. Preparation and In Vivo Characterization of Niosomal Carriers of the Antidiabetic Drug Repaglinide. Int J Pharm Sci Nanotechnol [Internet]. 2015 Feb 28 [cited 2021 Jan 26];8(1):2756–67. Available from: https://www.ijpsnonline.com/index.php/ijpsn/article/view/764
Hasan AA, Madkor H, Wageh S. Formulation and evaluation of metformin hydrochloride-loaded niosomes as controlled release drug delivery system. Drug Deliv. 2013;20(3–4):120–6.
Kesharwani P, Gorain B, Low SY, Tan SA, Ling ECS, Lim YK, et al. Nanotechnology based approaches for anti-diabetic drugs delivery. Diabetes Res Clin Pract. 2018;136:52–77.
Sahoo RK, Biswas N, Guha A, Kuotsu K. Maltodextrin based proniosomes of nateglinide: Bioavailability assessment. Int J Biol Macromol [Internet]. 2014;69:430–4. Available from: http://dx.doi.org/10.1016/j.ijbiomac.2014.05.075
Samed N, Sharma V, Sundaramurthy A. Hydrogen bonded niosomes for encapsulation and release of hydrophilic and hydrophobic anti-diabetic drugs: An efficient system for oral anti-diabetic formulation. Appl Surf Sci [Internet]. 2018;449(August 2020):567–73. Available from: http://dx.doi.org/10.1016/j.apsusc.2017.11.055
Prasad PS, Imam SS, Aqil M, Sultana Y, Ali A. QbD-based carbopol transgel formulation: Characterization, pharmacokinetic assessment and therapeutic efficacy in diabetes. Drug Deliv. 2016;23(3):1057–66.
Sankhyan A, Pawar PK. Metformin loaded non-ionic surfactant vesicles: Optimization of formulation, effect of process variables and characterization. DARU, J Pharm Sci. 2013;21(1):1–8.
Fawzy R, Rahman A, El-gamil MA. ce pt e d cr. J Liposome Res [Internet]. 2018;0(0):000. Available from: http://dx.doi.org/10.1080/08982104.2018.1556291
Rathi J, Tamizharasi S, Dubey A, Rathi V. Development and characterization of niosomal drug delivery of gliclazide. J Young Pharm. 2009;1(3):205.
Haider MF, Kanoujia J, Tripathi CB, Arya M, Kaithwas G, Saraf SA. Pioglitazone Loaded Vesicular Carriers for Anti-Diabetic Activity: Development and Optimization as Per Central Composite Design. J Pharm Sci Pharmacol. 2015;2(1):11–20.
Bodade SS, Shaikh KS, Kamble MS, Chaudhari PD. A study on ethosomes as mode for transdermal delivery of an antidiabetic drug. Drug Deliv. 2013;20(1):40–6.
Shah P, Chavda K, Vyas B, Patel S. Formulation development of linagliptin solid lipid nanoparticles for oral bioavailability enhancement: role of P-gp inhibition. Drug Deliv Transl Res. 2020;
Bose S, Sharma P, Mishra V, Patial S, Saraogi GK, Tambuwala MM, et al. Comparative in vitro evaluation of glimepiride containing nanosuspension drug delivery system developed by different techniques. J Mol Struct. 2021;1231.
Akhtar J, Siddiqui HH, Fareed S, Badruddeen, Khalid M, Aqil M. Nanoemulsion: for improved oral delivery of repaglinide. Drug Deliv. 2016;23(6):2026–34.
Ahmed OAA, Afouna MI, El-Say KM, Abdel-Naim AB, Khedr A, Banjar ZM. Optimization of self-nanoemulsifying systems for the enhancement of in vivo hypoglycemic efficacy of glimepiride transdermal patches. Expert Opin Drug Deliv. 2014;11(7):1005–13.
Panda BP, Krishnamoorthy R, Bhattamisra SK, Shivashekaregowda NKH, Seng L Bin, Patnaik S. Fabrication of Second Generation Smarter PLGA Based Nanocrystal Carriers for Improvement of Drug Delivery and Therapeutic Efficacy of Gliclazide in Type-2 Diabetes Rat Model. Sci Rep [Internet]. 2019;9(1):1–15. Available from: http://dx.doi.org/10.1038/s41598-019-53996-4
Mirazi N, Shoaei J, Khazaei A, Hosseini A. A comparative study on effect of metformin and metformin-conjugated nanotubes on blood glucose homeostasis in diabetic rats. Eur J Drug Metab Pharmacokinet. 2015;40(3):343–8.
Ismail R, Bocsik A, Katona G, Gróf I, Deli MA, Csóka I. Encapsulation in polymeric nanoparticles enhances the enzymatic stability and the permeability of the glp-1 analog, liraglutide, across a culture model of intestinal permeability. Pharmaceutics. 2019;11(11):1–13.
Yu L, Li C, Le Y, Chen JF, Zou H. Stabilized amorphous glibenclamide nanoparticles by high-gravity technique. Mater Chem Phys [Internet]. 2011;130(1–2):361–6. Available from: http://dx.doi.org/10.1016/j.matchemphys.2011.06.049
How to Cite
Copyright (c) 2022 MAHMOUD H. TEAIMA, MOSTAFA I. GEBRIL, FATHY I. ABD ALLAH, MOHAMED A. EL-NABARAWI
This work is licensed under a Creative Commons Attribution 4.0 International License.